Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 59

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 59
---
 on the
our balance sheets attributable to common stock will be reduced proportionally based on the Reverse Stock Split ratio, and the additional
paid-in capital will be credited with the amount by which the capital is reduced. The net income or loss per share of common stock will
be increased as a result of the fewer shares of common stock outstanding. The Reverse Stock Split will be reflected retroactively in our
consolidated financial statements.

<div align='center'>The Board of Directors recommends a vote “FOR” the approval of the Reverse Stock Split. The Board of

Directors retains the discretion to abandon, and not implement, the aforementioned amendments at any

time before they become effective.

34

PROPOSAL 4</div>

RATIFICATION OF THE SELECTION OF RBSM LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024

Proposal: The Board of Directors is asking
that you vote to ratify the Board’s selection of RBSM LLP (“RBSM”) as our independent registered public accounting firm
for fiscal year 2025.

During the year ended
December 31, 2024, and 2023, we engaged RBSM LLP as our independent registered public accounting firm. For the years ended December 31,
2024, and 2023, we incurred fees, as discussed below:

|                       |     | Fiscal Year Ended 
 December 31,      |    2024 |     |   |    2023 |
|:----------------------|:----|:------------------|--------:|:----|:--|--------:|
| Audit Fees(1)         |     | $                 | 163,069 |     | $ | 182,000 |
| Audit-Related Fees(2) |     |                   | 135,000 |     |   |  65,000 |
| Tax Fees              |     |                   |       - |     |   |       - |
| All Other Fees        |     |                   |       - |     |   |       - |
| Total                 |     | $                 | 298,069 |     | $ | 247,000 |

| (1) | Audit fees consist of fees relating to the audit of the Company’s annual consolidated financial statements and reviews of interim condensed consolidated financial statements. |

| (2) | Audit-related fees consisted of reviews of the Company’s registration statements, consents, and the completion of